info@RegenProtocols.com
561-325-7000
141 NW 20th St., Suite G1 Boca Raton, FL 33431
A multi-system regenerative framework for complex orthopedic recovery, combining peptides, mitochondrial support, and sleep optimization under close supervision.
A multi-system regenerative framework for complex orthopedic recovery, advanced tissue repair, and structural regeneration. The protocol combines angiogenic peptides, chondroprotective compounds, immune modulators, mitochondrial support, and growth hormone secretagogues to optimize recovery after major surgery or extensive structural injury.
It is intended for cases that need sustained, multi-phase remodeling under close clinical supervision.
| Agent | Route | Dose | Frequency | Duration |
|---|---|---|---|---|
| BPC-157 | SubQ (local and systemic) | 500 mcg local + 250 mcg systemic | Twice daily | 12 weeks |
| TB-500 (thymosin β4) | SubQ | 2.0 mg | Twice weekly (Weeks 1–4), then weekly (Weeks 5–12) | 12 weeks |
| AOD-9604 | SubQ | 300–600 mcg | Daily | 12 weeks |
| GHK-Cu | SubQ and topical | 2 mg SubQ plus topical application | Daily | 12 weeks |
| KPV | SubQ | 500 mcg | Daily | 6 weeks (front-loaded) |
| CJC-1295 / Ipamorelin | SubQ | 100 mcg / 100 mcg | Once daily (evening) | 12–16 weeks |
| DSIP | SubQ | 100–200 mcg | Once nightly (30 minutes before bed) | 4–8 weeks |
This is the most comprehensive and aggressive regenerative protocol in the orthopedic series. Reserve it for complex cases under close supervision.
The dual BPC-157 strategy provides both targeted perilesional repair and systemic anti-inflammatory support. TB-500 enhances cellular migration into damaged tissue, while AOD-9604 supports cartilage preservation and structural remodeling. GHK-Cu enhances collagen synthesis and restoration of the extracellular matrix. KPV reduces inflammatory signaling in the early phase. CJC-1295/ipamorelin raise systemic growth hormone and IGF-1 to sustain long-term tissue remodeling. DSIP improves deep sleep architecture, which is critical for growth hormone–mediated repair.
